NOT KNOWN DETAILS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-mobile Tumors: In rodent research, semaglutide has become revealed to trigger thyroid C-mobile tumors. It really is not known whether or not this risk applies to people, but semaglutide is contraindicated in people with a personal or relatives heritage of medullary thyroid carcinoma (MTC) or individuals with Multiple Endocrine Neoplasia s